Diagnostics & Biomarkers Asia 2012
Advancing into the New Frontier of Personalized Healthcare
30 - 31 Oct 2012, Shanghai, China
Dear Professional
According to recent reports, the global in vitro diagnostic (IVD) market is estimated to reach USD 53.5 billion in 2013. Key drivers include increased patient awareness and development of novel and affordable technologies, especially in the field of molecular diagnostics and biomarkers. In addition, advancements in biomarker discoveries and development have led to the increasing realization of personalized healthcare, driving strategic collaborations between pharma and diagnostic companies in developing companion diagnostics for targeted therapies.
Diagnostics & Biomarkers Asia 2012, part of the longest running Diagnostics conference series in Asia, brings together the diagnostic and pharmaceutical industry to discuss the latest industry trends and highlights technological and scientific advancement driving the industry growth. On top of strategic discussions on growth strategies and market development, this meeting will also critically examine the current development of personalized healthcare and industry collaboration models in Asia. Be a part of this conference today to find out the LATEST and understand how you should strategize your business and research in this booming industry. And Many More to Be Announced!
KEY THEMES include:
1. Development & Commercialization of Diagnostics & Biomarkers in Asia
2. Collaboration & Advances in Personalised Healthcare & Companion Diagnostics
3. Recent Advances in Disease Diagnosis
4. Innovations & Breakthroughs in Platform Technologies
5. Biomarkers in Drug Development & Enabling Technologies
6. Diagnostic & Prognostic Biomarkers
7. Molecular Diagnostics
8. Point of Care Diagnostics
9. Market Development & Growth Strategies
For more information,
Call: + 65 6508 2401 / +86 21 2326 3680
Email: register@ibcasia.com.sg
Web: http://www.diagnostics-biomarkersasia.com
